Investigating the role of a specific FOXP3 protein variant in asthma severity
FOXP3 ΔE2 isoform in asthma severity and persistence
This study is looking at a special version of a protein that might affect how severe and long-lasting asthma can be, using mice to learn more about how it impacts the immune system and allergy symptoms, which could help find new ways to treat asthma for people like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11103365 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific variant of the FOXP3 protein, known as the ΔE2 isoform, affects the severity and persistence of asthma. By using specially developed mouse models, the researchers will explore how this variant influences the immune response, particularly in relation to allergic airway inflammation. The study aims to identify the mechanisms by which the ΔE2 isoform contributes to asthma symptoms, potentially leading to new therapeutic strategies. Patients may benefit from insights gained about the role of FOXP3 in asthma management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with persistent asthma or severe allergic reactions.
Not a fit: Patients with asthma that is well-controlled or those without allergic components may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better manage asthma symptoms and improve patient quality of life.
How similar studies have performed: While the specific focus on the FOXP3 ΔE2 isoform is novel, previous research has shown that targeting immune regulatory pathways can lead to significant advancements in asthma treatment.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Zhou, Baohua — Indiana University Indianapolis
- Study coordinator: Zhou, Baohua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.